最近研究成果 1. Xiaohe Li, Yinshan Fang, Dingyuan Jiang, Yingying Dong, Yingying Liu, Si Zhang, Jiasen Guo, Chao Qi, Chenjing Zhao, Fangxin Jiang, Yueyue Jin, Jing Geng, Cheng Yang, Hongkai Zhang, Bin Wei, Jiurong Liang, Chen Wang, Huaping Dai, Honggang Zhou(*), Dianhua Jiang(*), Wen Ning(*). Targeting FSTL1 for multiple fibrotic and systemic autoimmune diseases. Mol Ther, 2021, Jan 6;29(1):347-364. 2. Shitong Xiang, Tianyue Jiang, Ziying Ke, Yingchun Shang, Wen Ning(*), Zhuo Yang(*), Tao Zhang(*). Knockdown of Follistatin-like 1 disrupts synaptic transmission in hippocampus and leads to cognitive impairments. Experimental Neurology. 2020, 333:113412 3. Lei Wang, Jie Liu, Wang Wang, Xianmei Qi, Bo Tian, Huaping Dai, Wen Ning(*), Ting Yang(*), Chen Wang(*). IL-17 deteriorates hypoxic pulmonary hypertension via upregulating b-catenin. Thorax 2019, 74(6):564-578 1. Zhongjie Chen, Yinshan Fang, Si Zhang, Lian Li, Li Wang, Aixu Zhang, Zhiyong Yuan, Ping Wang, Honggang Zhou, Wanchang Cui, Thomas J. MacVittie, Wen Ning(*). Haplodeletion of Follistatin-like 1 Attenuates Radiation-induced Pulmonary Fibrosis in Mice. Inter J Radio Onco Biol Phys. 2019, 103(1): 208-216, 2. Yingying Dong, Yan Geng, Lian Li, Xiaohe Li, Xiaohua Yan, Yinshan Fang, Xinxin Li, Siyuan Dong, Xue Liu, Xue Li, Xiuhong Yang, Xiaohong Zheng, Ting Xie, Jiurong Liang, Huaping Dai, Xinqi Liu, Zhinan Yin, Paul Noble, Dianhua Jiang(*) and Wen Ning(*) . Blocking Follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice. J Exp Med, 2015. 212(2): 235-252 |
|
|